CLINICAL_TRIALS
trial_result
· 2018-03-29
Clinical Trial Update: Ciclosporin to Reduce Reperfusion Injury in Primary PCI [Phase 2]
Summary
A Phase 2 study evaluating ciclosporin to reduce myocardial reperfusion injury during primary PCI has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Myocardial Reperfusion Injury | Phase 2 | Status: COMPLETED